IOL CHEM AND PHARMA LTD (IOLCP) financials

IOL CHEM AND PHARMA LTD (IOLCP) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.

IOL Chemicals & Pharmaceuticals Ltd is a leading pharmaceutical (APIs) company and is a significant player in the specialty chemicals space. It serves the domestic and export market.[1]It is the largest player of Ibuprofen (pain killer) globally with a world market share of 35%.[2]

Market Cap: ₹5,715Cr.
Current Price: ₹195
Stock P/E: 32.4
ROE: 8.42%
ROCE: 11.3%
Book Value: ₹61.3
Dividend Yield: 0.51%
52W High / Low: ₹224/67.1

In Jun 2026, IOL CHEM AND PHARMA LTD (IOLCP) reported sales ₹756 Cr and net profit ₹64 Cr.

Annual TTM: sales ₹2,524 Cr, net profit ₹168 Cr.

Shareholding: Promoters 62.28% (Sep 2026), FIIs 7.26% (Sep 2026), DIIs 0.30% (Sep 2026), Public 30.16% (Sep 2026), No. of Shareholders 1,32,241% (Sep 2026).

IOLCP quarterly results (₹ Cr.)
Category	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	526	523	528	552	568	580	619	756
Expenses	484	476	465	490	510	523	527	653
Operating Profit	42	47	63	62	57	57	93	104
OPM %	8%	9%	12%	11%	10%	10%	15%	14%
Other Income	6	4	5	7	7	-6	2	8
Interest	4	4	4	4	3	4	3	4
Depreciation	18	19	19	20	20	20	20	21
Profit before tax	26	28	45	46	41	28	71	87
Tax %	26%	26%	30%	25%	26%	25%	25%	26%
Net Profit	19	21	32	34	30	21	53	64
EPS in Rs	0.65	0.70	1.08	1.16	1.02	0.70	1.81	2.20
Raw PDF	—	—	—	—	—	—	—	—

IOLCP profit and loss (₹ Cr.)
Category	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	1,894	1,967	2,184	2,217	2,133	2,079	2,319	2,524
Expenses	1,321	1,375	1,927	1,990	1,901	1,877	2,049	2,213
Operating Profit	574	592	257	227	232	202	270	310
OPM %	30%	30%	12%	10%	11%	10%	12%	12%
Other Income	16	24	17	25	30	22	9	11
Interest	21	6	8	16	16	15	15	14
Depreciation	36	39	43	46	63	72	80	82
Profit before tax	533	571	223	189	183	138	184	226
Tax %	32%	22%	26%	26%	26%	27%	25%	—
Net Profit	361	445	166	140	135	101	138	168
EPS in Rs	12.70	15.15	5.64	4.77	4.61	3.44	4.69	5.73
Dividend Payout %	5%	8%	14%	17%	22%	23%	21%	—

IOLCP balance sheet (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	57	57	59	59	59	59	59	59
Reserves	417	757	1,202	1,332	1,448	1,553	1,629	1,740
Borrowings	284	59	3	44	80	33	117	135
Other Liabilities	184	297	347	526	434	600	577	653
Total Liabilities	942	1,170	1,610	1,960	2,021	2,244	2,382	2,587
Fixed Assets	412	469	512	561	751	933	1,170	1,181
CWIP	27	19	48	105	90	101	22	96
Investments	0	0	1	2	20	21	21	21
Other Assets	503	682	1,048	1,292	1,159	1,190	1,168	1,289
Total Assets	942	1,170	1,610	1,960	2,021	2,244	2,382	2,587

IOLCP cash flows (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity	273	471	380	91	123	290	179	214
Cash from Investing Activity	-63	-184	-317	-121	-119	-191	-154	-198
Cash from Financing Activity	-197	-272	-58	-2	-4	-92	46	-29
Net Cash Flow	13	15	4	-31	-0	7	70	-13
Free Cash Flow	213	391	272	-60	-86	18	-34	44
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit	83%	102%	88%	60%	75%	144%	97%	93%

IOLCP shareholding pattern (%)
Category	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Promoters	52.62%	52.62%	52.62%	52.62%	52.62%	57.48%	62.28%	62.28%
FIIs	1.49%	1.47%	2.59%	2.25%	2.08%	1.72%	4.87%	7.26%
DIIs	0.08%	0.07%	0.02%	0.05%	0.03%	0.02%	0.43%	0.30%
Public	45.81%	45.84%	44.76%	45.10%	45.26%	40.78%	32.41%	30.16%
No. of Shareholders	1,26,701	1,30,002	1,25,040	1,36,129	1,33,531	1,31,550	1,19,311	1,32,241

IOLCP key ratios
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	43	52	56	79	83	81	90	95
Inventory Days	66	64	98	95	77	111	95	91
Days Payable	42	62	79	95	74	123	112	118
Cash Conversion Cycle	67	55	74	79	86	69	73	68
Working Capital Days	43	46	66	71	72	71	58	53
ROCE %	56%	68%	54%	18%	14%	12%	9%	11%

IOLCPUpdated 17 Oct 2026, 17:02

Iol Chem And Pharma Ltd

IOLCPUpdated 17 Oct 2026, 17:02

Market Cap

₹5,715Cr.

Current Price

₹195

High / Low

₹224/67.1

Stock P/E

32.4

ROE8.42%

ROCE11.3%

Book Value₹61.3

Face Value₹2.00

Dividend Yield0.51%

About

Quarterly results

Last reported quarters₹ Cr.

Quarter	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Jun 2023	563	4	490	7	14	62	25	46	1.57
Sep 2023	545	4	481	7	16	51	26	38	1.29
Dec 2023	520	4	476	8	16	32	28	23	0.79
Mar 2024	504	3	454	8	16	38	25	28	0.96
Jun 2024	502	2	452	7	17	39	24	30	1.01
Sep 2024	526	4	484	6	18	26	26	19	0.65
Dec 2024	523	4	476	4	19	28	26	21	0.7
Mar 2025	528	4	465	5	19	45	30	32	1.08
Jun 2025	552	4	490	7	20	46	25	34	1.16
Sep 2025	568	3	510	7	20	41	26	30	1.02
Dec 2025	580	4	523	-6	20	28	25	21	0.7
Mar 2026	619	3	527	2	20	71	25	53	1.81
Jun 2026	756	4	653	8	21	87	26	64	2.2

Profit & loss

Annual statement₹ Cr.

Year	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Mar 2015	385	59	373	1	29	-75	-12	-67	-2.8
Mar 2016	580	61	529	1	30	-39	4	-40	-1.42
Mar 2017	711	68	608	1	30	6	21	5	0.17
Mar 2018	983	64	863	6	30	31	12	28	0.99
Mar 2019	1685	51	1276	10	32	336	30	237	8.32
Mar 2020	1894	21	1321	16	36	533	32	361	12.7
Mar 2021	1967	6	1375	24	39	571	22	445	15.15
Mar 2022	2184	8	1927	17	43	223	26	166	5.64
Mar 2023	2217	16	1990	25	46	189	26	140	4.77
Mar 2024	2133	16	1901	30	63	183	26	135	4.61
Mar 2025	2079	15	1877	22	72	138	27	101	3.44
Mar 2026	2319	15	2049	9	80	184	25	138	4.69
TTM	2524	14	2213	11	82	226	—	168	5.73

Shareholding pattern

As of Sep 2026%

Holder	Share
Promoters	62.28%
FIIs	7.26%
DIIs	0.3%
Public	30.16%

Shareholding trend

Ownership over time%

Quarter	Promoters	FIIs	DIIs	Public
Dec 2023	48.19%	2.18%	0.36%	49.27%
Mar 2024	48.19%	1.4%	0.29%	50.11%
Jun 2024	48.19%	1.39%	0.09%	50.34%
Sep 2024	48.19%	1.63%	0.07%	50.11%
Dec 2024	52.62%	1.49%	0.08%	45.81%
Mar 2025	52.62%	1.47%	0.07%	45.84%
Jun 2025	52.62%	2.59%	0.02%	44.76%
Sep 2025	52.62%	2.25%	0.05%	45.1%
Dec 2025	52.62%	2.08%	0.03%	45.26%
Mar 2026	57.48%	1.72%	0.02%	40.78%
Jun 2026	62.28%	4.87%	0.43%	32.41%
Sep 2026	62.28%	7.26%	0.3%	30.16%

Balance sheet

Assets & liabilities₹ Cr.

Period	Equity Capital	Reserves	Borrowings	Other Liabilities	Total Liabilities	Fixed Assets	CWIP	Investments	Other Assets	Total Assets
Mar 2015	48	160	400	94	702	403	4	0	295	702
Mar 2016	56	129	453	135	772	400	4	0	369	772
Mar 2017	56	132	447	182	817	374	21	0	422	817
Mar 2018	56	160	422	214	852	406	7	0	439	852
Mar 2019	57	417	284	184	942	412	27	0	503	942
Mar 2020	57	757	59	297	1170	469	19	0	682	1170
Mar 2021	59	1202	3	347	1610	512	48	1	1048	1610
Mar 2022	59	1332	44	526	1960	561	105	2	1292	1960
Mar 2023	59	1448	80	434	2021	751	90	20	1159	2021
Mar 2024	59	1553	33	600	2244	933	101	21	1190	2244
Mar 2025	59	1629	117	577	2382	1170	22	21	1168	2382
Mar 2026	59	1740	135	653	2587	1181	96	21	1289	2587

Cash flows

Operating, investing & financing₹ Cr.

Period	Operating	Investing	Financing	Net cash flow
Mar 2015	-47	-5	50	-2
Mar 2016	18	-27	9	0
Mar 2017	83	-23	-60	1
Mar 2018	120	-50	-70	-1
Mar 2019	273	-63	-197	13
Mar 2020	471	-184	-272	15
Mar 2021	380	-317	-58	4
Mar 2022	91	-121	-2	-31
Mar 2023	123	-119	-4	0
Mar 2024	290	-191	-92	7
Mar 2025	179	-154	46	70
Mar 2026	214	-198	-29	-13

Key ratios

Historical financial ratios

Category	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	31	55	58	54	43	52	56	79	83	81	90	95
Inventory Days	279	201	201	109	66	64	98	95	77	111	95	91
Days Payable	92	102	115	83	42	62	79	95	74	123	112	118
Cash Conversion Cycle	218	154	144	80	67	55	74	79	86	69	73	68
Working Capital Days	59	39	36	23	43	46	66	71	72	71	58	53
ROCE %	-3%	4%	12%	15%	56%	68%	54%	18%	14%	12%	9%	11%

Frequently asked questions

Quick answers about this company's financials on Fincrux

What is the market cap of IOL CHEM AND PHARMA LTD (IOLCP)?

The reported market capitalisation for IOL CHEM AND PHARMA LTD (IOLCP) is ₹5,715Cr. on Fincrux. Figures may update with market data and filings.

What is the current share price of IOLCP?

The current price shown for IOL CHEM AND PHARMA LTD (IOLCP) on Fincrux is ₹195 with a 52-week high/low of ₹224/67.1.

What is the P/E ratio of IOL CHEM AND PHARMA LTD (IOLCP)?

The stock P/E for IOL CHEM AND PHARMA LTD (IOLCP) is 32.4 on Fincrux, with ROE at 8.42% and ROCE at 11.3%.

What were IOLCP latest quarterly results?

For Jun 2026, IOL CHEM AND PHARMA LTD (IOLCP) reported sales ₹756 Cr and net profit ₹64 Cr (figures in ₹ crore unless noted).

What are IOLCP annual sales and net profit?

For TTM, IOL CHEM AND PHARMA LTD (IOLCP) shows sales of ₹2,524 Cr and net profit of ₹168 Cr on the Fincrux profit & loss statement.

Who owns IOL CHEM AND PHARMA LTD (IOLCP)?

Latest shareholding for IOL CHEM AND PHARMA LTD (IOLCP) on Fincrux: Promoters 62.28% (Sep 2026), FIIs 7.26% (Sep 2026), DIIs 0.30% (Sep 2026), Public 30.16% (Sep 2026), No. of Shareholders 1,32,241% (Sep 2026).

Where can I find IOL CHEM AND PHARMA LTD (IOLCP) financials?

IOL CHEM AND PHARMA LTD (IOLCP) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.

Does Fincrux show IOLCP balance sheet and cash flow?

Yes. The IOL CHEM AND PHARMA LTD (IOLCP) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 17 October 2026 at 17:02